This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Subarachnoid Hemorrhage
and you are
between 18 and 75
years old
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

The purpose of this study is to examine the effects of the study drug--Galantamine—on patients with subarachnoid hemorrhage (SAH). The study will examine how patients with SAH will tolerate the study drug and how it may improve brain functioning in patients after SAH.

Provided treatments

  • Drug: Placebo
  • Drug: 8mg galantamine twice daily
  • Drug: 12mg galantamine twice daily

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02872857. The sponsor of the trial is The University of Texas Health Science Center, Houston and it is looking for 60 volunteers for the current phase.
Official trial title:
A Pilot Parallel Double-Blind, Randomized Trial of Galantamine for Subarachnoid Hemorrhage